The firm will withdraw its planned IPO after being told that it would have to take a 30 to 40 percent discount to its valuation, its CEO said.
The lab has partnered with both WaferGen and Fluidigm to improve throughput for the barcode sequencing protocol it has developed for transcriptome profiling.
The partners will combine the sciFlexarrayer with Anteo's reagents to improve the functionality and shelf-life of activated glass and polymer slides and other arrays.
The developers of the method are now using the ddPCR approach to create and test assays for early colon cancer detection.
Quanterix has won a second GE NFL Head Health Challenge I grant and will use it to develop diagnostics with biomarkers discovered under the first grant.
In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.
In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.
The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.
The NIH has issued a preliminary guidance for newborn dried blood spot research.